Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07600827

Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain Syndrome

This randomized controlled trial aims to investigate the effects of isokinetic training combined with blood flow restriction (BFR) in individuals with patellofemoral pain syndrome (PFPS).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants aged 18 to 40 years.
  • Clinical diagnosis of patellofemoral pain syndrome (PFPS).
  • Presence of anterior or retropatellar knee pain for at least 3 months.
  • Pain provoked by at least two activities that increase patellofemoral joint load, including squatting, stair climbing, running, jumping, prolonged sitting, or kneeling.
  • Average knee pain intensity of ≥3 on a 10-point visual analog scale (VAS) during aggravating activities.
  • Ability to participate in exercise training and attend scheduled intervention sessions.
  • Willingness to provide written informed consent.

Exclusion criteria

  • History of knee surgery or significant trauma to the lower extremity within the previous 12 months.
  • Clinical evidence of other knee disorders, including ligament injury, meniscal injury, patellar instability, osteoarthritis, or tendinopathy.
  • Presence of neurological, cardiovascular, or systemic musculoskeletal disorders that may affect lower limb function or exercise participation.
  • Current participation in other structured lower extremity rehabilitation or strength training programs.
  • Contraindications to blood flow restriction training, including uncontrolled hypertension, vascular disease, thromboembolic disorders, or clotting abnormalities.
  • Use of pain-relieving injections or surgical interventions for knee pain within the previous 6 months.
  • Pregnancy.
  • Inability to complete the assessment or intervention procedures.

Treatment and study plan

Isokinetic training

Device

Participants in this group will receive supervised isokinetic muscle strength training targeting the knee musculature using an isokinetic dynamometer. Each session will last 30 minutes throughout the intervention period.

Isokinetic Training Combined With Blood Flow Restriction

Device

Participants in this group will receive isokinetic muscle strength training combined with blood flow restriction (BFR). BFR will be applied to the proximal thigh using a pneumatic cuff at an individualized pressure based on limb occlusion pressure. Isokinetic training will target the knee musculature using an isokinetic dynamometer under supervised conditions. Each session will last 30 minutes, with training performed multiple times per week throughout the intervention period.

Aerobic Cycling Exercise

Device

Participants in this group will receive supervised aerobic cycling exercise using a stationary bicycle. Training will be performed at a moderate intensity for 30 minutes per session throughout the intervention period.

Primary outcomes

  1. Anterior Knee Pain Scale (AKPS)

    Time frame: From enrollment to the end of treatment at 4 weeks

    The AKPS is a validated questionnaire used to assess pain and functional limitations associated with patellofemoral pain syndrome. Scores range from 0 to 100, with higher scores indicating better knee function and fewer symptoms.

Study contacts

Contact information is provided by the study sponsor or research team.

Jingzhi Zhang

CONTACT

[email protected]

+86-16677137704

Sponsors and collaborators

Lead sponsor

Nanjing Mingzhou Rehabilitation Hospital

Other

Collaborators

  • Guilin institute of information technology

Registry information

Official study title

Effects of Isokinetic Training Combined With Blood Flow Restriction in Patellofemoral Pain Syndrome

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 22, 2026
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.